Your browser doesn't support javascript.
loading
ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer.
Xu, Guotai; Chhangawala, Sagar; Cocco, Emiliano; Razavi, Pedram; Cai, Yanyan; Otto, Jordan E; Ferrando, Lorenzo; Selenica, Pier; Ladewig, Erik; Chan, Carmen; Da Cruz Paula, Arnaud; Witkin, Matthew; Cheng, Yuanming; Park, Jane; Serna-Tamayo, Cristian; Zhao, HuiYong; Wu, Fan; Sallaku, Mirna; Qu, Xuan; Zhao, Alison; Collings, Clayton K; D'Avino, Andrew R; Jhaveri, Komal; Koche, Richard; Levine, Ross L; Reis-Filho, Jorge S; Kadoch, Cigall; Scaltriti, Maurizio; Leslie, Christina S; Baselga, José; Toska, Eneda.
Afiliación
  • Xu G; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Chhangawala S; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Cocco E; Physiology, Biophysics, and Systems Biology Program, Weill Cornell Graduate School, New York, NY, USA.
  • Razavi P; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Cai Y; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Otto JE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ferrando L; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Selenica P; Depatment of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Ladewig E; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Chan C; Department of Internal Medicine, Università degli Studi di Genova, Genova, Italy.
  • Da Cruz Paula A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Witkin M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Cheng Y; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Park J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Serna-Tamayo C; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Zhao H; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Wu F; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Sallaku M; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Qu X; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Zhao A; Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Collings CK; Tumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • D'Avino AR; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Jhaveri K; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Koche R; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Levine RL; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Reis-Filho JS; Depatment of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Kadoch C; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Scaltriti M; Depatment of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Leslie CS; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Baselga J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Toska E; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nat Genet ; 52(2): 198-207, 2020 02.
Article en En | MEDLINE | ID: mdl-31932695

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Factores de Transcripción / Neoplasias de la Mama / Receptores de Estrógenos / Resistencia a Antineoplásicos / Proteínas de Unión al ADN Tipo de estudio: Observational_studies / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Factores de Transcripción / Neoplasias de la Mama / Receptores de Estrógenos / Resistencia a Antineoplásicos / Proteínas de Unión al ADN Tipo de estudio: Observational_studies / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos